注射用尤瑞克林治疗急性进展型脑梗死患者32例的疗效观察

发布时间：2018-03-20 11:08

本文选题：进展型脑梗死　切入点：尤瑞克林　出处：《中风与神经疾病杂志》2017年04期 　论文类型：期刊论文

【摘要】：正急性进展型脑梗死是指脑梗死患者发病后神经功能缺失症状在48 h内逐渐进展或呈阶梯式加重,治疗目的主要是恢复缺血脑组织的供血供氧,促进神经功能恢复,急性进展型脑梗死的治疗有很多,包括溶栓、抗凝、抑制血小板聚集、清除氧自由基以及神经保护等~([1]),虽然溶栓治疗是治疗急性缺血性卒中最有效的方法,但其严格的适应证和时间窗要
[Abstract]:Positive acute progressive cerebral infarction (ACI) refers to the progressive or stepwise exacerbation of neurological deficit in patients with cerebral infarction within 48 hours. The main purpose of treatment is to restore blood supply and oxygen supply to ischemic brain tissue and to promote the recovery of nerve function. There are many treatments for acute progressive cerebral infarction, including thrombolysis, anticoagulation, inhibition of platelet aggregation, scavenging of oxygen free radicals, and neuroprotection ([1]), although thrombolytic therapy is the most effective treatment for acute ischemic stroke. But its strict indication and time window must
【作者单位】：吉化集团公司总医院神经内科;
【分类号】：R743.33

【相似文献】